ETF Holdings Breakdown of STRO

STRO institutional holdings

The following institutional investment holdings of STRO have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	50,688	USD 41,214 0.9%	0.81
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	50,688	USD 41,214 0.9%	0.81
Total =		101,376	USD 82,428

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with STRO

Analysts Set Sutro Biopharma, Inc. (NASDAQ:STRO) PT at $6.11

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have earned a consensus rating of “Hold” from the eight analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating on […] - 2025-07-14 02:56:47

Vontobel Holding Ltd. Has $33,000 Stake in Sutro Biopharma, Inc. (NASDAQ:STRO)

Vontobel Holding Ltd. lifted its stake in shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 100.0% during the first quarter, Holdings Channel.com reports. The firm owned 50,000 shares of the company’s stock after buying an additional 25,000 shares during the period. Vontobel Holding Ltd.’s holdings in Sutro Biopharma were worth $33,000 at the […] - 2025-07-10 05:02:54

Exchange Traded Concepts LLC Buys 91,363 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO)

Exchange Traded Concepts LLC lifted its stake in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 201.9% in the 1st quarter, Holdings Channel reports. The institutional investor owned 136,623 shares of the company’s stock after acquiring an additional 91,363 shares during the period. Exchange Traded Concepts LLC’s holdings in Sutro Biopharma were worth $89,000 as […] - 2025-06-25 04:58:52

Sutro Biopharma (NASDAQ:STRO) Raised to Overweight at Piper Sandler

Sutro Biopharma (NASDAQ:STRO – Get Free Report) was upgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a note issued to investors on Monday, MarketBeat.com reports. The firm currently has a $2.00 target price on the stock. Piper Sandler’s target price would indicate a potential upside of […] - 2025-06-18 02:22:53

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given a consensus recommendation of “Hold” by the eight analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating on […] - 2025-06-16 02:37:01

Sutro Biopharma, Inc. (NASDAQ:STRO) Holdings Lowered by Man Group plc

Man Group plc decreased its stake in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 19.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 132,406 shares of the company’s stock after selling 31,522 shares during the quarter. Man Group plc’s holdings in Sutro Biopharma […] - 2025-05-28 05:00:52

OMERS ADMINISTRATION Corp Decreases Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO)

OMERS ADMINISTRATION Corp lowered its stake in shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 50.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 95,150 shares of the company’s stock after selling 95,150 shares during the period. OMERS […] - 2025-05-21 05:26:52

Dimensional Fund Advisors LP Grows Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO)

Dimensional Fund Advisors LP boosted its position in shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 15.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,136,457 shares of the company’s stock after purchasing an additional 156,139 shares during the period. Dimensional Fund Advisors LP’s holdings in Sutro Biopharma were worth $2,091,000 at […] - 2025-05-15 04:32:46

Hsbc Holdings PLC Has $116,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO)

Hsbc Holdings PLC reduced its position in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 22.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 63,554 shares of the company’s stock after selling 18,111 shares during the period. Hsbc Holdings PLC […] - 2025-05-12 04:58:52

XTX Topco Ltd Trims Position in Sutro Biopharma, Inc. (NASDAQ:STRO)

XTX Topco Ltd trimmed its position in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 79.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 21,809 shares of the company’s stock after selling 82,391 shares during the period. XTX Topco Ltd’s holdings in Sutro Biopharma were […] - 2025-05-02 05:12:54

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $6.63 Consensus PT from Analysts

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received a consensus rating of “Hold” from the nine research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have given a buy recommendation to […] - 2025-04-30 02:34:46

Prudential Financial Inc. Acquires 426,100 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO)

Prudential Financial Inc. boosted its holdings in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) by 351.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 547,510 shares of the company’s stock after acquiring an additional 426,100 shares during the quarter. Prudential Financial Inc.’s holdings […] - 2025-04-07 04:43:09

China Universal Asset Management Co. Ltd. Purchases New Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO)

China Universal Asset Management Co. Ltd. purchased a new stake in Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 17,484 shares of the company’s stock, valued at approximately $32,000. Other hedge funds […] - 2025-02-05 06:46:53

Back to Listing

Disclaimer